Besides the beneficial effects of intranasal insulin in preclinical studies, a case study described a patient with manganese-induced parkinsonism whose motor and cognition symptoms improved after four weeks of intranasal treatment with insulin [204]. This evidence concerns the gene INS and Parkinson disease.